March 22, 2022 10:11am

AGTC priced at $1.189 per share for offering

AGTC announced the pricing of its previously announced underwritten public offering of 7,500,000 shares of its common stock for gross proceeds of approximately $9.8 million, before deducting the underwriting discounts and commissions and other estimated offering expenses payable by AGTC. 

All of the shares are being sold by AGTC.

 The offering is expected to close on or about March 24, 2022, subject to customary closing conditions.

In addition, AGTC has granted to the underwriter a 30-day option to purchase up to approximately 1,125,000 additional shares of its common stock.

Cantor Fitzgerald & Co. is acting as the sole book-running manager for the offering.


The Bottom Line: BAD timing and DESPARATE move! Would have been better if new clinical DATA was an impedes